Wu Wenxun, Yin Detao, Yang Weimin, Kan Quancheng, Liu Zhangsuo, Ren Xiaoyan, Zhai Chenguang, Zhang Shengjun
Department of Metabolic and Endocrine Disorders, First Affiliated Hospital of Zhengzhou University, No.1 Jianshe Road East, Zhengzhou, Henan Province, China, 450052.
Cochrane Database Syst Rev. 2014 Mar 4;2014(3):CD010492. doi: 10.1002/14651858.CD010492.pub2.
A thyroid nodule is a discrete lesion within the thyroid gland that might be palpable and is ultrasonographically distinct from the surrounding thyroid parenchyma. Thyroid nodules are more common as age increases and occur more frequently in women. Benign thyroid nodules often cause pressure symptoms and cosmetic complaints. In China and many other countries, doctors use Chinese herbal medicines (CHM) to treat thyroid nodules.
To assess the effects of Chinese herbal medicines in the treatment of benign thyroid nodules in adults.
Review authors searched the following electronic databases: The Cochrane Library, MEDLINE, EMBASE, the Chinese Biomedical Literature Database (CBM), the China National Knowledge Infrastructure (CNKI), VIP information (a Chinese database), WANFANG Data (a Chinese database), the Chinese Conference Papers Database and the Chinese Dissertation Database (all searched up to April 2013).
Randomised controlled trials comparing CHM or CHM plus levothyroxine versus levothyroxine, placebo or no treatment in adults with benign thyroid nodules.
Two review authors independently extracted data, assessed studies for risk of bias and evaluated overall study quality according to GRADE (Grading of Recommendations Assessment, Development and Evaluation), with differences resolved by consensus.
We included one randomised trial involving 152 participants with a randomisation ratio of 2:1 (CHM vs no treatment). The trial applied adequate sequence generation; however, allocation concealment was unclear. Duration of treatment was three months, and follow-up six months. Our a priori defined outcomes of interest (i.e. nodule volume reduction ≥ 50%; pressure symptoms, cosmetic complaints or both; health-related quality of life; all-cause mortality; cancer occurrence; changes in number and size of thyroid nodules; changes in thyroid volume; and socioeconomic effects) were not investigated in the included study. Thyrotropin (TSH), thyroxine (T4) and tri-iodothyronine (T3) serum levels were normal in both groups before and after the trial was conducted. No adverse events were reported (low quality evidence).
AUTHORS' CONCLUSIONS: Firm evidence cannot be found to support or refute the use of Chinese herbal medicines for benign thyroid nodules in adults.
甲状腺结节是甲状腺内的一种离散性病变,可能可触及,在超声检查中与周围甲状腺实质不同。甲状腺结节随着年龄增长更为常见,且在女性中更为频发。良性甲状腺结节常引起压迫症状和美容方面的问题。在中国和许多其他国家,医生使用中药来治疗甲状腺结节。
评估中药治疗成人良性甲状腺结节的效果。
综述作者检索了以下电子数据库:考克兰图书馆、医学期刊数据库(MEDLINE)、荷兰医学文摘数据库(EMBASE)、中国生物医学文献数据库(CBM)、中国知网(CNKI)、维普资讯(一个中文数据库)、万方数据(一个中文数据库)、中国会议论文数据库和中国学位论文数据库(均检索至2013年4月)。
比较中药或中药加左甲状腺素与左甲状腺素、安慰剂或不治疗对成人良性甲状腺结节治疗效果的随机对照试验。
两名综述作者独立提取数据,评估研究的偏倚风险,并根据推荐分级的评估、制定与评价(GRADE)对总体研究质量进行评价,分歧通过协商解决。
我们纳入了一项随机试验,涉及152名参与者,随机分组比例为2:1(中药组与不治疗组)。该试验采用了适当的序列生成方法;然而,分配隐藏情况不明。治疗持续时间为3个月,随访6个月。纳入研究未对我们预先定义的感兴趣结局(即结节体积缩小≥50%;压迫症状、美容方面的问题或两者兼有;健康相关生活质量;全因死亡率;癌症发生;甲状腺结节数量和大小的变化;甲状腺体积的变化;以及社会经济影响)进行调查。试验前后两组的促甲状腺激素(TSH)、甲状腺素(T4)和三碘甲状腺原氨酸(T3)血清水平均正常。未报告不良事件(低质量证据)。
未找到确凿证据支持或反驳中药用于治疗成人良性甲状腺结节。